Reviews on New Drug Targets in Age-Related Disorders

Reviews on New Drug Targets in Age-Related Disorders
Author :
Publisher : Springer Nature
Total Pages : 274
Release :
ISBN-10 : 9783030550356
ISBN-13 : 3030550354
Rating : 4/5 (354 Downloads)

Book Synopsis Reviews on New Drug Targets in Age-Related Disorders by : Paul C. Guest

Download or read book Reviews on New Drug Targets in Age-Related Disorders written by Paul C. Guest and published by Springer Nature. This book was released on 2021-03-16 with total page 274 pages. Available in PDF, EPUB and Kindle. Book excerpt: Aging is an inevitable part of life, and is becoming a worldwide social, economic and health problem due to the fact that an increasing proportion of individuals in the advanced age category have a higher probability of developing age-related disorders. New therapeutic approaches are still in need to decrease or slow the effects of such diseases in this aging society. Advances in ‘omic technologies such as genomics, transcriptomics, proteomics and metabolomics have significantly advanced our understanding of diseases in multiple medical areas. It is hoped that emerging hits from these analyses might be prioritized for further screening as potential novel drug targets for increasing the human healthspan in line with the lifespan, which will in turn lead to new therapeutic strategies and drug development projects by the pharmaceutical industry. This new book presents a series of reviews describing studies which have resulted in the identification of potential new drug targets for age-related disorders. Much of this information has come from ‘omic comparisons of healthy and disease states or from testing the effects of potential new therapeutic approaches. Each chapter will be presented in the context of specific chronic diseases or different therapeutic strategies, providing important information on disease mechanisms related to the aging process. This book will be of interest to researchers in the areas of aging and chronic disease, as well as clinical scientists, physicians, and major drug companies. With contributors from Australia, Brazil, Canada, France, Germany, India, Iran, Iraq, South Africa, South Korea, Thailand, Ukraine, United Kingdom, United States of America, Uruguay and Vietnam, this is a timely follow up to Guest’s previous book Reviews on New Drug Targets in Age-Related Disorders.


Reviews on New Drug Targets in Age-Related Disorders Related Books

Reviews on New Drug Targets in Age-Related Disorders
Language: en
Pages: 274
Authors: Paul C. Guest
Categories: Science
Type: BOOK - Published: 2021-03-16 - Publisher: Springer Nature

GET EBOOK

Aging is an inevitable part of life, and is becoming a worldwide social, economic and health problem due to the fact that an increasing proportion of individual
Reviews on New Drug Targets in Age-Related Disorders
Language: en
Pages: 343
Authors: Paul C. Guest
Categories: Science
Type: BOOK - Published: 2020-04-17 - Publisher: Springer Nature

GET EBOOK

Aging is an inevitable part of life and is becoming a worldwide social, economic and health problem. This is mainly due to the fact that the increasing proporti
Reviews on New Drug Targets in Age-Related Disorders
Language: en
Pages: 340
Authors: Paul C. Guest
Categories: Science
Type: BOOK - Published: 2020-06-07 - Publisher: Springer

GET EBOOK

Aging is an inevitable part of life and is becoming a worldwide social, economic and health problem. This is mainly due to the fact that the increasing proporti
Anti-aging Drugs
Language: en
Pages: 592
Authors: Alexander M Vaiserman
Categories: Medical
Type: BOOK - Published: 2017-01-18 - Publisher: Royal Society of Chemistry

GET EBOOK

Aging is a natural phenomenon that is peculiar to all living things. However, accumulating findings indicate that senescence could be postponed or prevented by
Alzheimer's Disease Drug Development
Language: en
Pages: 575
Authors: Jeffrey Cummings
Categories: Business & Economics
Type: BOOK - Published: 2022-03-31 - Publisher: Cambridge University Press

GET EBOOK

Provides a definitive overview of the complex ecosystem facilitating Alzheimer's Disease drug research and development. Demonstrates a drug's journey from in th